Richard G. Ball

Richard G. Ball publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Richard G. Ball sits on this spectrum.

Richard G. Ball D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard G. Ball sits on this spectrum.

Overview

Best Publications

• Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.

  Sheo B Singh;Hiranthi Jayasuriya;John G Ondeyka;Kithsiri B Herath

  296
  Citations

• Structure−Activity Relationship of Heterobase-Modified 2‘-C-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication

  Anne B Eldrup;Marija Prhavc;Jennifer Brooks;Balkrishen Bhat

  241
  Citations

• Synthesis and structure of dicarbonylbis(.eta.-pentamethylcyclopentadienyl)diiridium

  Unknown

  231
  Citations

• Nodulisporic Acid A, a Novel and Potent Insecticide from a Nodulisporium Sp. Isolation, Structure Determination, and Chemical Transformations

  John G. Ondeyka;Gregory L. Helms;Otto D. Hensens;Michael A. Goetz

  203
  Citations

• Total Synthesis and Determination of the Absolute Configuration of Epibatidine

  Stephen R. Fletcher;Raymond Baker;Mark S. Chambers;Richard H. Herbert

  192
  Citations

• Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties

  Paul J. Coleman;John D. Schreier;Christopher D. Cox;Michael J. Breslin

  173
  Citations

• Piperidine-ether based hNK1 antagonists 1: Determination of the relative and absolute stereochemical requirements

  T. Harrison;B.J. Williams;C.J. Swain;R.G. Ball

  171
  Citations

• 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels

  Ian Collins;Christopher Moyes;William B Davey;Michael Rowley

  155
  Citations

• A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429).

  William R. Schoen;Judith M. Pisano;Kristine Prendergast;Matthew J. Wyvratt

  145
  Citations

• 1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor

  Peter D. Williams;Paul S. Anderson;Richard G. Ball;Mark G. Bock

  135
  Citations

• Aryl sulfones : A new class of γ-secretase inhibitors

  Martin Teall;Paul Oakley;Timothy Harrison;Duncan Shaw

  116
  Citations

• Preussomerins and Deoxypreussomerins: Novel Inhibitors of Ras Farnesyl-Protein Transferase

  Sheo B. Singh;Deborah L. Zink;Jerrold M. Liesch;Richard G. Ball

  116
  Citations

• Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation.

  Craig A. Parish;Scott K. Smith;Kathleen Calati;Deborah Zink

  115
  Citations

• Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas.

  José L. Castro;Richard G. Ball;Howard B. Broughton;Michael G. N. Russell

  111
  Citations

• Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.

  Richard W Friesen;Yves Ducharme;Richard G Ball;Marc Blouin

  106
  Citations

• Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

  Scott D. Edmondson;Cheng Zhu;Nam Fung Kar;Jerry Di Salvo

  105
  Citations

• Activation of dihydrogen by ruthenium(II)-chelating phosphine complexes, and activation of dioxygen by ruthenium(II) porphyrin complexes: an update

  Brian R. James;A. Pacheco;S.J. Rettig;I.S. Thorburn

  97
  Citations

• Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine "antagonist"

  Daniele Simoni;Johannes Stoelwinder;Alan P. Kozikowski;Kenneth M. Johnson

  94
  Citations

• Zaragozic acid A, a potent inhibitor of squalene synthase: initial chemistry and absolute stereochemistry

  Kenneth E. Wilson;Robert M. Burk;Tesfaye Biftu;Richard G. Ball

  93
  Citations

• An Efficient Preparation of Vinamidinium Hexafluorophosphate Salts

  Ian W. Davies;Jean-Francois Marcoux;Jimmy Wu;Michael Palucki

  93
  Citations

• Asymmetric Synthesis of α,α-Difluoro-β-amino Acid Derivatives from Enantiomerically Pure <i>N-tert-</i>Butylsulfinimines

  Unknown

  93
  Citations

• Tryptophan-derived NK1 antagonists: conformationally constrained heterocyclic bioisosteres of the ester linkage.

  Richard T. Lewis;Angus M. Macleod;Kevin J. Merchant;Fintan Kelleher

  92
  Citations

• Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid

  Alex M. Chen;Martha E. Ellison;Andrey Peresypkin;Robert M. Wenslow

  88
  Citations